Translational Challenges
Global Health
Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases.
Infectious diseases disregard national borders. They are some of the biggest threats facing human health.
We collaborate with experts in this space and use our expertise in translation to help remove barriers and progress promising science.
We are currently refreshing our global health strategy and look forward to sharing more information later this year.
What do we want to achieve?
Focusing our efforts where patient need is greatest and listening to those with lived experiences, we aim to:
- improve understanding of infections
- connect experts across global health research
- support sustainable capacity growth
- contribute to making innovations affordable and accessible
- unblock barriers that keep solutions from reaching patients
How we work
Partnerships
We pursue collaborations that:
- Focus on urgent needs in infections
- Aim to create a more equitable and sustainable global research ecosystem
Funding
We invest in projects that:
- Aim to bring innovations closer to patients and align with our strategy
Scientific support
Our team can help you:
- Translate new therapeutics
- Develop diagnostics and biomarkers
- Discover and humanise antibodies
- Protect your intellectual property
Partnerships and initiatives
Grand Challenges African Drug Discovery Accelerator programme
In collaboration with the Bill & Melinda Gates Foundation we are investing £6 million in the Grand Challenges African Drug Discovery Accelerator (GC ADDA) programme.
PACE
A £30 million initiative with Innovate UK and Medicines Discovery Catapult, driving new developments to tackle antimicrobial resistance.
iiCON and the Liverpool School of Tropical Medicine
We are partnering with the Liverpool School of Tropical Medicine (LSTM) to launch a new £2.7 million Translational Development Fund.
The Francis Crick Institute and the Crick Africa Network
We have partnered with the Crick Africa Network (CAN), to provide £7.5 million towards community science programmes.
Who to contact
-
Ghada Zoubiane
Read bio: Ghada Zoubiane
-
Magalie Rocheville
Read bio: Magalie Rocheville
-
Kelly Chibale
Read bio: Kelly Chibale
-
Julie Brady
Read bio: Julie Brady
Related stories
-
News releasesLifeArc joins transatlantic collaboration to develop a treatment for Crimean-Congo Hemorrhagic Fever
Read more: LifeArc joins transatlantic collaboration to develop a treatment for Crimean-Congo Hemorrhagic Fever -
News releases3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Read more: 3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late -
News releasesTackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
Read more: Tackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
See our other Translational Challenges
Motor Neuron Disease
Our vision is a world where motor neuron disease is preventable and treatable.
Chronic Respiratory Infection
Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis.
Rare Disease
Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster.
Childhood Cancer
Our vision is to drive life-changing innovations for children with cancer.
Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.
This site is protected by reCAPTCHA and the Google privacy policy and terms apply.